4-(2,3-dichlorophenyl)butanoic acid | 57915-83-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(2,3-dichlorophenyl)butanoic acid
• 英文别名: 4-(2,3-dichlorophenyl)butyric acid
• CAS: 57915-83-0
• 化学式: C₁₀H₁₀Cl₂O₂
• 分子量: 233.094
• InChiKey: FXEBLUSEFUKMQC-UHFFFAOYSA-N

物化性质

• 沸点：
  354.4±27.0 °C(Predicted)
• 密度：
  1.341±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(2,3-dichlorophenyl)butanoic acid 在 溴 作用下， 以 1,4-二氧六环 、 乙醚 为溶剂， 反应 59.67h， 生成 9,10-dichloro-5,6-dihydro-4aH-naphtho[1,2-e][1,3,4]thiadiazin-3-amine
  参考文献：
  名称：

  [EN] COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION
  [FR] COMPOSÉS POUR INHIBER LA PROLIFÉRATION CELLULAIRE

  摘要：

  公开号：

  WO2012006068A3
• 作为产物：
  描述：

  2,3-二氯苯甲醛 在 platinum on activated charcoal 盐酸 、 氢气 、 sodium amide 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 1.0h， 生成 4-(2,3-dichlorophenyl)butanoic acid
  参考文献：
  名称：

  Synthesis and β-adrenergic properties of tetrahydronaphthalene analogs of dichloroisoproterenol

  摘要：

  The tetrahydronaphthalene analogs 4 and 5 of DCI (3b) and of its N-unsubstituted derivative (3a) were synthesized and tested for their beta-adrenergic properties by means of both binding tests and functional tests. Compounds 4 and 5 proved to possess a good affinity for beta-adrenergic receptors accompanied by an appreciable beta-blocking activity, thus indicating that the formal insertion of a beta-blocking drug such as DCI into a tetrahydronaphthalene structure is able to provide compounds which still possess a beta-blocking activity.

  DOI：

  10.1016/0223-5234(93)90034-c

文献信息

• Compounds for the Inhibition of Cellular Proliferation
  申请人：Chorev Michael

  公开号：US20130178505A1

  公开（公告）日：2013-07-11

  Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, (4) disorders associated with viral infections, and/or (5) non-proliferative metabolic disorders such as type II diabetes where inhibition of translation initiation is beneficial using the compounds disclosed herein.

  提供了抑制翻译的组合物和方法。本文披露的化合物可用于治疗以下疾病：（1）细胞增殖性疾病，（2）非增殖性退行性疾病，（3）病毒感染，（4）与病毒感染有关的疾病，以及（5）非增殖性代谢性疾病，如II型糖尿病，其中抑制翻译起始有益。本文还提供了用于治疗上述疾病的方法和试剂盒。
• Compounds for the inhibition of cellular proliferation
  申请人：Chorev Michael

  公开号：US08969573B2

  公开（公告）日：2015-03-03

  Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, (4) disorders associated with viral infections, and/or (5) non-proliferative metabolic disorders such as type II diabetes where inhibition of translation initiation is beneficial using the compounds disclosed herein.

  提供了用于抑制翻译的组合物和方法。本文披露的化合物可用于治疗(1)细胞增殖性疾病、(2)非增殖性退行性疾病、(3)病毒感染、(4)与病毒感染相关的疾病以及/或(5)抑制翻译起始对非增殖性代谢性疾病的治疗有益。本文还提供了用于治疗上述疾病的组合物、方法和试剂盒。
• Synthesis of Rigidified eIF4E/eIF4G Inhibitor-1 (4EGI-1) Mimetic and Their in Vitro Characterization as Inhibitors of Protein–Protein Interaction
  作者：Poornachandran Mahalingam、Khuloud Takrouri、Ting Chen、Rupam Sahoo、Evangelos Papadopoulos、Limo Chen、Gerhard Wagner、Bertal H. Aktas、Jose A. Halperin、Michael Chorev

  DOI：10.1021/jm401733v

  日期：2014.6.26

  The 4EGI-1 is the prototypic inhibitor of eIF4E/eIF4G interaction, a potent inhibitor of translation initiation in vitro and in vivo and an efficacious anticancer agent in animal models of human cancers. We report on the design, synthesis, and in vitro characterization of a series of rigidified mimetic of this prototypic inhibitor in which the phenyl in the 2-(4-(3,4-dichlorophenyl)thiazol-2-yl) moiety was bridged into a tricyclic system. The bridge consisted one of the following: ethylene, methylene oxide, methylenesulfide, methylenesulfoxide, and methylenesulfone. Numerous analogues in this series were found to be markedly more potent than the parent prototypic inhibitor in the inhibition of eIF4E/eIF4G interaction, thus preventing the eIF4F complex formation, a rate limiting step in the translation initiation cascade in eukaryotes, and in inhibition of human cancer cell proliferation.
• COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION
  申请人：President and Fellows of Harvard College

  公开号：EP2585453A2

  公开（公告）日：2013-05-01
• 1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP2590944B1

  公开（公告）日：2015-09-30